Danaher Corporation has agreed to acquire Masimo in a cash deal worth $9.9bn in an effort to broaden its diagnostics business in the telehealth space. Under the deal, which is valued at a price per ...
Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) in an all-cash transaction valued at approximately $9.9 billion, as the ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which ...
Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio. The acquisition values the device maker at $180 per share and ...
A U.S. jury ruled on November 15, 2025, that Apple must pay Masimo $634 million in a patent infringement case over smartwatch technology, awarding Masimo a major victory after years of litigation.
The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund’s 13F assets under management. Initiated a new position valued at about $203 million ...
Masimo shares rocketed after biotech conglomerate Danaher struck a deal to acquire the medical-device maker for almost $10 billion. Masimo shares (MASI) surged by roughly one-third Tuesday morning to ...
Medical technology company Masimo (MASI) has agreed to be acquired by Danaher Corporation (DHR) for $180 per share in cash, valuing the deal at approximately $9.9 billion. California-based Masimo's ...
Feb 17 (Reuters) - Danaher (DHR.N), opens new tab, a $150 billion U.S. company that makes tools used in developing and testing medicines, on Tuesday agreed to buy Masimo (MASI.O), opens new tab for $9 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal is expected to close in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results